Amarin boosted as another milestone to the FDA’s big Vascepa decision flies by with no sign of an AdCom
Amarin stock got a boost Wednesday morning as the company posted a nice spike in Vascepa sales for the latest quarter and company execs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
